Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Physiomics Plc (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C12417)・商品コード:DATA904C12417
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offers model based drug development services, which includes population PKPD analysis of clinical data, back-translational analysis, optimal design of future studies. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects. Physiomics partners with small and large pharmaceutical and biotechnology companies. Physiomics is headquartered at Oxford, England, the UK.

Physiomics Plc (PYC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Physiomics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Physiomics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Physiomics Plc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Physiomics Partners with Pharma Company 10
Physiomics Plans to Enter into Co-Development Agreement with Diatech Pharmacogenetics 11
Equity Offering 12
Physiomics Raises USD0.7 Million in Private Placement of Shares 12
Physiomics Raises USD0.7 Million in Private Placement of Shares 13
Physiomics Raises USD0.4 Million in Private Placement of Shares 14
Physiomics Raises USD0.4 Million in Private Placement of Shares 15
Physiomics Raises USD0.9 Million in Private Placement 16
Physiomics Announces Private Placement Of Shares For US$6.3 Million 17
Physiomics Plc – Key Competitors 18
Physiomics Plc – Key Employees 19
Physiomics Plc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Oct 08, 2018: Physiomics: Final Results for the year ended 30 June 2018 21
Feb 19, 2018: Physiomics: Interim Results Statement for the six-month period ended 31 December 2017 23
Oct 16, 2017: Physiomics: Final Results for the year ended 30 June 2017 25
Mar 24, 2017: Physiomics Announces Interim Results Statement for the six month period ended 31 December 2016 29
Government and Public Interest 31
Mar 14, 2018: Physiomics: Award of New Innovate UK Grant 31
Mar 12, 2018: Physiomics: Completion of Innovate UK Grant Project on Personalised Treatment of Oesophageal Cancer 32
Feb 09, 2018: Physiomics secures third major pharmaceutical client in matter of months 33
Jan 06, 2017: Physiomics: Confirmation of Award of Innovate UK Grant 34
Other Significant Developments 35
Oct 02, 2017: Physiomics: Company update 2017 35
May 24, 2017: Physiomics Provides Update on Two Further Extension Projects to Advance Oncology Candidate With Global Pharma Company 36
Jan 11, 2017: Physiomics: Company Update 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Physiomics Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Physiomics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Physiomics Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Physiomics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Physiomics Partners with Pharma Company 10
Physiomics Plans to Enter into Co-Development Agreement with Diatech Pharmacogenetics 11
Physiomics Raises USD0.7 Million in Private Placement of Shares 12
Physiomics Raises USD0.7 Million in Private Placement of Shares 13
Physiomics Raises USD0.4 Million in Private Placement of Shares 14
Physiomics Raises USD0.4 Million in Private Placement of Shares 15
Physiomics Raises USD0.9 Million in Private Placement 16
Physiomics Announces Private Placement Of Shares For US$6.3 Million 17
Physiomics Plc, Key Competitors 18
Physiomics Plc, Key Employees 19

List of Figures
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C12417)販売に関する免責事項を必ずご確認ください。
★調査レポート[Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆